Vijaya Diagnostic Centre Limited (NSE: VIJAYA, BSE: 543350) is a Hyderabad, Telangana-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹14,231 Cr, it ranks #483 by market cap among the 6,137 Indian listed companies on FinBizNet, and #1 of 18 in Medical Diagnostic Centres. At ₹1,389.40 (as of 25 Oct 2026), the share price is 12.8% below its 52-week high of ₹1,593.60 and 63.8% above its 52-week low of ₹848.00. The share price is up 40.7% over one year and up 5.7% over three months.
| Current Price | ₹1,389.40 |
|---|---|
| Market Cap | ₹14,231 Cr |
| NSE Symbol | VIJAYA |
| BSE Code | 543350 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | 81.5 |
| Return on Equity | 19.70% |
| Return on Assets | 11.02% |
| 52-Week Range | ₹848.00 – ₹1,593.60 |
| 1-Year Price Change | +40.7% |
| 3-Month Price Change | +5.7% |
| Beta (1Y) | 0.85 |
| Dividend Yield | 0.15% |
| Headquarters | Hyderabad, Telangana |
| Website | www.vijayadiagnostic.com |
| Revenue | ₹231 Cr |
|---|---|
| Net Profit | ₹53 Cr |
| Net Margin | 23.0% |
| EPS (Basic) | ₹5.16 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.
1. Diagnostic Services-This segment offers diagnostic services.
1. Diagnostic Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Limited | ₹14,231 Cr | 81.5 | 19.70% | ₹231 Cr | +40.7% |
| Metropolis Healthcare Limited | ₹11,002 Cr | 56.7 | 13.37% | ₹450 Cr | +7.3% |
| Throcare Technologies Ltd | ₹7,737 Cr | 46.3 | 28.74% | ₹240 Cr | +8.9% |
| Dr. Agarwal'S Eye Hospital Ltd | ₹2,465 Cr | 34.5 | 25.22% | — | +20.0% |
| Krsnaa Diagnostics Ltd | ₹1,730 Cr | 16.6 | 10.89% | ₹236 Cr | -38.8% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,597 Cr | 48.2 | 13.84% | ₹88 Cr | -0.3% |
| Gaudium IVF and Women Health Limited | ₹738 Cr | 25 | 16.08% | ₹19 Cr | — |
| Chandan Healthcare Limited | ₹583 Cr | 21.5 | — | ₹81 Cr | — |
| Star Imaging And Path Lab Limi | ₹136 Cr | 6.2 | — | — | -43.0% |
Listed by market capitalisation. Ratios are shown for context only.
Vijaya Diagnostic Centre Limited is trading at ₹1,389.40, with a market capitalisation of ₹14,231 Cr.
Vijaya Diagnostic Centre Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Vijaya Diagnostic Centre Limited has a P/E of 81.5 and a return on equity of 19.70%.
Vijaya Diagnostic Centre Limited is listed on the NSE under the symbol VIJAYA and on the BSE under the scrip code 543350.
Vijaya Diagnostic Centre Limited's share price is up 40.7% over one year and up 5.7% over three months. Its 52-week range is ₹848.00 to ₹1,593.60.
In Q1 FY27, Vijaya Diagnostic Centre Limited reported revenue of ₹231 Cr and net profit of ₹53 Cr, with basic EPS of ₹5.16 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.